Human AP3D1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human AP3D1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human AP3D1 |
| Clone | polyclonal |
| Host Species | Goat |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mg |
| Concentration | 1ug/ul |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This affinity purified antibody is directed against human AP3D1. The product was affinity purified from antiserum by immunoaffinity purification. A BLAST analysis was used to suggest reactivity with this protein from human, chimpanzee and chicken based on 100% homology for the immunogen sequence. Cross reactivity with AP3D1 protein from mouse, rat, dog and cow may occur as sequence homology varies by only one amino acid residue in this sequence as indicated by BLAST analysis. Reactivity with AP3D1 proteins from other sources is not known. AP3D1 (also known as Delta-adaptin 3, AP-3 complex delta subunit and Deltaadaptin) is a subunit of the AP3 adaptor-like complex, which is not associated with clathrin. The AP3D1 subunit is implicated in in |
| Immunogen | Immunogen: This affinity purified antibody was prepared from whole goat serum produced by repeated immunizations with a synthetic peptide corresponding aa 686-698 of Human AP3D1. |
| Other Names | [AP3D1 protein; AP-3 complex subunit delta-1; adaptor related protein complex 3 subunit delta 1] |
| Gene, Accession # | [AP3D1], Gene ID: 8943 |
| Catalog # | MBS4158586 |
| Price | $540 |
| Order / More Info | Human AP3D1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies